All About Multiple Sclerosis

More MS news articles for March 2004

Nitric oxide synthase expression and enzymatic activity in multiple sclerosis

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15016008

Acta Neurol Scand. 2004 Apr;109(4):261-9
Broholm H, Andersen B, Wanscher B, Frederiksen JL, Rubin I, Pakkenberg B, Larsson HB, Lauritzen M.
Department of Pathology, Glostrup Hospital, Denmark.

We used post-mortem magnetic resonance imaging (MRI) guidance to obtain paired biopsies from the brains of four patients with clinical definite multiple sclerosis (MS).

Samples were analyzed for the immunoreactivity (IR) of the three nitric oxide (NO) synthase isoforms [inducible, neuronal and endothelial nitric oxide synthase (NOS)], and enzymatic NO synthase activity.

MRI guided biopsies documented more active plaques than macroscopic examination, and histological examination revealed further lesions.

Inducible NOS (iNOS) was the dominant IR isoform, while reactive astrocytes were the dominant iNOS expressing cells in active lesions.

NOS IR expressing cells were widely distributed in plaques, in white and gray matter that appeared normal macroscopically, and on MR.

Endothelial NOS (eNOS) was highly expressed in intraparenchymal vascular endothelial cells of MS patients.

A control group matched for age and sex showed no such changes.

Our data support the hypothesis that NO is a pathogenic factor in MS, and that NOS IR is strongly expressed in brain regions appearing normal by MRI.